CLINICAL_TRIALS ClinicalTrials.gov record update

[PMS] LINZESS® Tablet 0.25mg Long-term Specified Drug Use-results Survey in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03471728
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:06.562352+00:00
Published At: 2024-10-18T00:00:00+00:00
Record Updated At: 2024-10-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Chronic Constipation (CC) (Excluding Constipation Due to Organic Diseases)", "Irritable Bowel Syndrome With Constipation (IBS-C)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-10-18"
protocolSection.identificationModule.nctId: "NCT03471728"
protocolSection.identificationModule.officialTitle: "[PMS] LINZESS\u00ae Tablet 0.25mg Long-term Specified Drug Use-results Survey in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.